Concepedia

Sadao Katayama

SK

Statistics

Publications

22

Citations

10.4K

H-Index

17

Active since

1987

Affiliations

Hiroshima University(Current)

National Center of Neurology and Psychiatry

Eli Lilly (United States)

Heidelberg University

Higashihiroshima Medical Center

Sadao Katayama is an author at Hiroshima University specializing in neuroscience, neurology, and neurodegeneration.

Publications per year

1987–2025

22

Publications

22

Lecanemab in Early Alzheimer’s Disease

Christopher H. van Dyck, Chad J. Swanson, Paul Aisen et al. · New England Journal of Medicine · 2022 · 5.2K citations · Full text

Life Sciences, Neurology, Neuroscience +17

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

Yoshiya Kawaguchi, Toshihiro Okamoto, Masafumi Taniwaki et al. · Nature Genetics · 1994 · 1.8K citations

Life Sciences, Genetics, Molecular Genetics +11

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

Rik Vandenberghe, Juha O. Rinne, Merçé Boada et al. · Alzheimer s Research & Therapy · 2016 · 299 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease

Frida Grynspan, William R. Griffin, Anne M. Cataldo et al. · Brain Research · 1997 · 156 citations

Life Sciences, Neurobiology, Neuroscience +17

1–5 of 22